Type 2 diabetes, in which the body doesn’t use insulin properly, is on the rise in the United States. There are more than 35 million people with the condition, and many are diagnosed when they are young, even in adolescence. Perhaps more astonishing—and worrying—is that prediabetes, the condition that leads to type 2 diabetes, now affects 96 million people. That’s one in three of us.
The good news is that prediabetes can be seen as a warning sign—it’s the body’s way of saying that your insulin levels are rising, but you can still reverse it before developing type 2 diabetes
The Goodbody Health Group Inc. is listed on the Canadian Securities Exchange (CSE), the Aquis Stock Exchange – Growth Market (AQSE) Apex segment, OTC and Frankfurt Stock Exchange (FSE), providing current and prospective shareholders with multiple platforms in which to buy and sell Goodbody Health Group Inc. stock under the EPIC codes: CSE: GDBY / AQSE: GDBY / FRA: 484 / OTC: GDBYF).